About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Profound Medical Corp. - common stock (NQ:PROF)

7.310 +0.040 (+0.55%)
Streaming Delayed Price Updated: 11:21 AM EDT, May 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Profound Medical Corp. - common stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Profound Medical to Release Second Quarter 2023 Financial Results on August 9 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Announces New CPT® Category 1 Codes from the AMA for TULSA to Treat Prostate Diseases
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Announces Upcoming Investor Events
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical: Q1 Earnings Insights ↗
 
Via Benzinga
News headline image
Earnings Preview For Profound Medical ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  On Wednesday, 200 companies hit new 52-week lows. 
Via Benzinga
News headline image
Recap: Profound Medical Q2 Earnings ↗
Profound Medical (NASDAQ:PROF) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Profound Medical to Participate in A.G.P.’s Virtual Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Annual and Special Meeting of Shareholders Voting Results
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Announces First Quarter 2023 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
News headline image
TULSA Procedure Featured in the Scientific Program at the American Urological Association 2023 Annual Meeting
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Release First Quarter 2023 Financial Results on May 10 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to to Participate in the 2023 Bloom Burton & Co. Healthcare Investor Conference
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023 ↗
 
Via Benzinga
News headline image
Profound Medical Announces Fourth Quarter and Full Year 2022 Financial Results
Company confirms Current Procedural Terminology (“CPT®”) Category 1 application for TULSA 
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Present at the 43rd Annual Cowen Health Care Conference
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Release Fourth Quarter and Full Year 2022 Financial Results on March 7 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Present at the 2022 Jefferies London Healthcare Conference
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical Announces Third Quarter 2022 Financial Results
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Profound Medical to Release Third Quarter 2022 Financial Results on November 3 – Conference Call to Follow
From Profound Medical Corp.
Via GlobeNewswire
News headline image
Why Cooper-Standard Is Trading Higher By 70%, Here Are 81 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Assure Holdings Corp. (NASDAQ: IONM) shares jumped 88.8% to $3.9650 after jumping around 104% on Thursday. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  Wednesday saw 127 companies set new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  On Wednesday, 297 companies achieved new lows for the year. 
Via Benzinga
News headline image
Why Quoin Pharmaceuticals Plunged Over 62%; Here Are 120 Biggest Movers From Friday ↗
Gainers 
Via Benzinga
News headline image
88 Biggest Movers From Yesterday ↗
Gainers Creatd, Inc. (NASDAQ: CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd’s board approved a rights offering of up to $40 million for 20 million shares at $2 per unit. 
Via Benzinga
News headline image
Earnings Scheduled For May 9, 2022 ↗
Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million. 
Via Benzinga
News headline image
Earnings Outlook For Profound Medical ↗
Profound Medical (NASDAQ:PROF) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement. Analysts estimate that Profound... 
Via Benzinga
News headline image
80 Biggest Movers From Yesterday ↗
Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 93.1% to close at $6.45 on Tuesday on above-average volume. XORTX Therapeutics Inc. (NASDAQ: XRTX) gained 59.1% to... 
Via Benzinga
News headline image
Recap: Profound Medical Q4 Earnings ↗
Profound Medical (NASDAQ:PROF) reported its Q4 earnings results on Thursday, March 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
News headline image
The Daily Biotech Pulse: NuCana Shelves Biliary Tract Cancer Study, Tricida Data Readout Pushed Back Due to Ukrainian Crisis, Synlogic Names New CFO ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus NuCana Discontinues Biliary Tract Cancer Study Following Futility Analysis... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.